MyAverix Finance
LSE · Healthcare
Poolbeg Pharma PLC (POLB)
Biotechnology
Poolbeg Pharma PLC (POLB) is listed on LSE in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for POLB
Poolbeg Pharma PLC (POLB) — FAQ
What is POLB's P/E ratio?
The price-to-earnings (P/E) ratio for Poolbeg Pharma PLC (POLB) is 25.00 (data as of 2026-05-23).
Does Poolbeg Pharma PLC pay a dividend?
Dividend yield is not available in the current snapshot for Poolbeg Pharma PLC (POLB). Check the MyAverix Finance app for the latest dividend data.
What sector is Poolbeg Pharma PLC in?
Poolbeg Pharma PLC (POLB) is classified in the Healthcare sector (Biotechnology industry).
What exchange is POLB listed on?
POLB is listed on LSE.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.